Second field tumors: A new opportunity for cancer prevention?

Oncologist

Volumn 10, Issue 7, 2005, Pages 493-500

  Braakhuis, Boudewijn J M ^a   Brakenhoff, Ruud H ^a   Leemans, C René ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cancer prevention; Head and neck cancer; Molecular diagnosis; Oral cancer; Squamous cell carcinoma

Indexed keywords

CANCER CLASSIFICATION; CANCER RISK; CANCER SURGERY; HEAD AND NECK CANCER; HUMAN; MINIMAL RESIDUAL DISEASE; MOUTH CANCER; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASMS, SECOND PRIMARY; PRECANCEROUS CONDITIONS; RISK FACTORS;

EID: 21344451578     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.10-7-493     Document Type: Review

References (48)

1. Bray F, Sankila R, Ferlay J et al. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002;38:99-166.
2. Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002;97:72-81.
3. Forastiere A, Koch W, Trotti A et al. Head and neck cancer. N Engl J Med 2001;345:1890-1900.
4. Leemans CR, Tiwari R, Nauta JJ et al. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 1994;73:187-190.
5. Leemans CR, Tiwari R, Nauta JJ et al. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 1993;71:452-456.
6. Sturgis EM, Miller RH. Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol 1995;104:946-954.
7. Snow GB, de Vries N, van Zandwijk N et al. Second primary cancers in the lung in head and neck cancer patients: a challenge. Eur J Cancer Clin Oncol 1987;23:883-886.
8. Braakhuis BJM, Tabor MP, Leemans CR et al. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 2002;24:198-206.
9. Looser KG, Shah JP, Strong EW. The significance of "positive" margins in surgically resected epidermoid carcinomas. Head Neck Surg 1978;1:107-111.
10. Pantel K, Cote RJ, Fodstad O. Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 1999;91:1113-1124.
11. Pindborg JJ, Reichart PA, Smith CJ et al. Histological typing of cancer and precancer in the oral mucosa. World Health Organization. Berlin: Springer Verlag, 1997:21-31.
12. Schepman KP, van der Meij EH, Smeele LE et al. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol 1998;34:270-275.
13. Rosin MP, Cheng X, Poh C et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 2000;6:357-362.
14. Sudbo J, Kildal W, Risberg B et al. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 2001;344:1270-1278.
15. Abbey LM, Kaugars GE, Gunsolley JC et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;80:188-191.
16. Karabulut A, Reibel J, Therkildsen MH et al. Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med 1995;24:198-200.
17. Warren S, Gates O. Multiple primary malignant tumors. A survey of the literature and a statistical study. Am J Cancer 1932;16:1358-1414.
18. Hong WK, Lippman SM, Itri LM et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990;323:795-801.
19. Bedi GC, Westra WH, Gabrielson E et al. Multiple head and neck tumors: evidence for acommon clonal origin. Cancer Res 1996;56:2484-2487.
20. Scholes AGM, Woolgar JA, Boyle MA et al. Synchronous oral carcinomas: independent or common clonal origin? Cancer Res 1998;58:2003-2006.
21. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ et al. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 2002;161:1051-1060.
22. Kim MM, Califano JA. Molecular pathology of head-and-neck cancer. Int J Cancer 2004;112:545-553.
23. Wreesmann VB, Shi W, Thaler HT et al. Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. J Clin Oncol 2004;22:3965-3972.
24. Beder LB, Gunduz M, Ouchida M et al. Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas. Lab Invest 2003;83:99-105.
25. Braakhuis BJM, Tabor MP, Kummer JA et al. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003;63:1727-1730.
26. Lee JJ, Hong WK, Hittelman WN et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 2000;6:1702-1710.
27. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953;6:963-968.
28. Tabor MP, Brakenhoff RH, van Houten VM et al. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res 2001;7:1523-1532.
29. Tabor MP, Braakhuis BJM, Van Der Wal JE et al. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx. J Pathol 2003;199:354-360.
30. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ et al. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study. Clin Cancer Res 2004;10:3607-3613.
31. Partridge M, Li SR, Pateromichelakis S et al. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. Clin Cancer Res 2000;6:2718-2725.
32. van Houten VM, Leemans CR, Kummer JA et al. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study. Clin Cancer Res 2004;10:3614-3620.
33. Califano J, Leong PL, Koch WM et al. Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships. Clin Cancer Res 1999;5:1862-1867.
34. Worsham MJ, Wolman SR, Carey TE et al. Common clonal origin of synchronous primary head and neck squamous cell carcinomas: analysis by tumor karyotypes and fluorescence in situ hybridization. Hum Pathol 1995;26:251-261.
35. Jang SJ, Chiba I, Hirai A et al. Multiple oral squamous epithelial lesions: are they genetically related? Oncogene 2001;20:2235-2242.
36. Sudbo J, Lippman SM, Lee JJ et al. The influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med 2004;350:1405-1413.
37. Hashibe M, Ritz B, Le AD et al. Radiotherapy for oral cancer as a risk factor for second primary cancers. Cancer Lett 2005;220:185-195.
38. Bongers V, Snow GB, de Vries N et al. Potential early markers of carcinogenesis in the mucosa of the head and neck using exfoliative cytology. J Pathol 1996;178:284-289.
39. van Houten VM, Tabor MP, van den Brekel MW et al. Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions. Clin Cancer Res 2000;6:3803-3816.
40. Rudin CM, Cohen EEW, Papadimitrakopoulou VA et al. An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia. J Clin Oncol 2003;21:4546-4552.
41. Franklin WA, Gazdar AF, Haney J et al. Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J Clin Invest 1997;100:2133-2137.
42. Prevo LJ, Sanchez CA, Galipeau PC et al. p53-mutant clones and field effects in Barrett's esophagus. Cancer Res 1999;59:4784-4787.
43. Rosenthal AN, Ryan A, Hopster D et al. Molecular evidence of a common clonal origin and subsequent divergent clonal evolution in vulval intraepithelial neoplasia, vulval squamous cell carcinoma and lymph node metastases. Int J Cancer 2002;99:549-554.
44. Chu TY, Shen CY, Lee HS et al. Monoclonality and surface lesion-specific microsatellite alterations in premalignant and malignant neoplasia of uterine cervix: a local field effect of genomic instability and clonal evolution. Genes Chromosomes Cancer 1999;24:127-134.
45. Jothy S, Slesak B, Harlozinska A et al. Field effect of human colon carcinoma on normal mucosa: relevance of carcinoembryonic antigen expression. Tumour Biol 1996;17:58-64.
46. Forsti A, Louhelainen J, Soderberg M et al. Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer. Eur J Cancer 2001;37:1372-1380.
47. Takahashi T, Habuchi T, Kakehi Y et al. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. Cancer Res 1998;58:5835-5841.
48. Stern RS, Bolshakov S, Nataraj AJ et al. p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet a-treated patients: evidence for heterogeneity and field cancerization. J Invest Dermatol 2002;119:522-526.